By David Bautz, PhD NASDAQ: ICU READ THE FULL ICU RESEARCH REPORT Business Update Statistically Significant Survival Benefit Shown for QUELIMMUNE® On October 22, 2026, SeaStar Medical Holding Corp. (ICU) announced the presentation of new positive data at the American Society of Nephrology (ASN) Kidney Week 2026. A copy of the presentation can be found here . The analysis compared survival in